These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3117973

  • 21. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ.
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
    Suzuki T, Higa S, Sakoda S, Ueji M, Hayashi A, Takaba Y, Nakajima A.
    Eur J Clin Pharmacol; 1982; 23(5):463-8. PubMed ID: 6818040
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T, Katsuyama M, Karai N, Nakamura M, Katsube J.
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [Abstract] [Full Text] [Related]

  • 26. An L-DOPA-like depressor action of L-threo-dihydroxyphenyl-serine in the rat caudal ventrolateral medulla.
    Furukawa N, Goshima Y, Miyamae T, Nishihama M, Okumura F, Fujita K, Misu Y.
    Life Sci; 1997 Feb; 61(12):1177-83. PubMed ID: 9315508
    [Abstract] [Full Text] [Related]

  • 27. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N, Kuroda H, Yamamoto M, Nukina I, Ota Z.
    Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli.
    Gwon HJ, Yoshioka H, Song NE, Kim JH, Song YR, Jeong DY, Baik SH.
    Prep Biochem Biotechnol; 2012 Jun; 42(2):143-54. PubMed ID: 22394063
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
    Harada H, Noto T, Tsuji M, Taga C, Hashimoto H, Nakajima T.
    Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
    [Abstract] [Full Text] [Related]

  • 32. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
    Araki H, Fujiwara H, Tanaka C.
    J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
    Boomsma F, van der Hoorn FA, Man in 't Veld AJ, Schalekamp MA.
    J Chromatogr; 1988 Jun 03; 427(2):219-27. PubMed ID: 3137237
    [Abstract] [Full Text] [Related]

  • 35. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E, Irie T, Katsube J.
    Jpn J Pharmacol; 1987 Jan 03; 43(1):91-3. PubMed ID: 3106684
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.